The CNT Success Story Begins, IDTechEx Forecasts Significant Growth
BOSTON, Sept. 25, 2020 /PRNewswire/ -- Carbon nanotubes (CNTs) have been known for many decades, but the moment of significant commercial growth is just approaching. Through expansions, partnerships, acquisitions, and…
Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
CAMBRIDGE, Mass., Sept. 25, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the…
Radius Health & Menarini Group Provide Elacestrant Update
WALTHAM, Mass. and FLORENCE, Italy, Sept. 25, 2020 /PRNewswire/ -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) and the Menarini Group today announced an update on the elacestrant Phase…